# Arthur Sackler **Arthur M. Sackler** (August 22, 1913 – May 26, 1987) was the eldest of the three Sackler brothers who bought the Purdue Frederick Company in 1952. A physician by training (NYU Medical School), Arthur made his career not in clinical medicine but in **pharmaceutical advertising and medical publishing** — fields he effectively created in their modern form. At the William Douglas McAdams advertising agency (which he eventually owned), Arthur pioneered the techniques that now define pharma marketing: direct-to-physician detailing, full-page color drug ads in medical journals (notably *The Journal of the American Medical Association*), sponsored continuing-medical-education programs, paid physician opinion-leaders, and the *Medical Tribune* (1960–), a weekly newspaper that reached 600,000 physicians and blurred the line between editorial content and pharma promotion. The Medical Advertising Hall of Fame credited him with shaping "pharmaceutical promotion as we know it today." His most lucrative engagement was the 1960s **Valium** (diazepam) campaign for Roche — Valium became the most-prescribed drug in America from 1968 to 1982 and the first pharmaceutical to top $100M in annual sales. Arthur took commission. Patrick Radden Keefe argues in *[[Empire of Pain]]* that the Valium campaign was the template for [[OxyContin]]'s 1990s marketing playbook — a Sackler-marketed drug promoted as safer than predecessors, prescribed at massive scale, and producing widespread iatrogenic dependence. The Sackler heirs dispute this parallel. **Arthur died in 1987**, eight years before [[OxyContin]]'s 1995 FDA approval. His one-third stake in the family enterprise was bought out by his brothers Mortimer and Raymond for $22.35M (ProPublica). His widow Jillian Sackler (d. June 2025) and his descendants — a branch that is neither "Side A" (Mortimer's family) nor "Side B" (Raymond's) in the bankruptcy — have argued continuously that Arthur bears no responsibility for the opioid crisis. *ProPublica* reporting in 2019 surfaced documents suggesting Arthur's heirs may have benefited indirectly via international affiliates; Arthur's heirs dispute this. See [[Sackler Family]] for the 1987 split between Arthur's branch and the Purdue Sacklers in detail. Arthur was also a prodigious **art collector** — particularly of Chinese and South Asian art — and a major museum philanthropist. The Arthur M. Sackler Gallery at the [[Smithsonian Institution]] (1987), the Sackler Wing of Egyptian Antiquities at the Metropolitan Museum (housing the Temple of Dendur, opened 1978), and the Arthur M. Sackler Museum at Harvard (now de-named, 2024) were his principal cultural footprints. The pattern of converting commercial wealth into civic legitimacy through art patronage is the Carnegie-Rockefeller-Mellon template — see [[Andrew Mellon]] for the archetype. ## See Also - [[Sackler Family]] — the dynasty - [[Mortimer Sackler]] — co-founder brother - [[Raymond Sackler]] — co-founder brother - [[Purdue Pharma]] — the 1952 acquisition - [[Opioid Crisis Timeline]] — Era 1 detail - [[Andrew Mellon]] — the philanthropy-as-laundering archetype